Supplemental material
Open access
1,749
Views
9
CrossRef citations to date
0
Altmetric
Original Article
Limited relevance and progression of histological alterations in the liver during thioguanine therapy in inflammatory bowel disease patients
Dirk P. van AsseldonkDepartment of Gastroenterology and Hepatology, Noordwest Ziekenhuis groep, Alkmaar, the Netherlands;
, Melek SimsekDepartment of Gastroenterology and Hepatology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; Correspondence[email protected]
http://orcid.org/0000-0001-8827-955X
Nanne K. H. de BoerDepartment of Gastroenterology and Hepatology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands;
, Bindia JharapMeander Medical Center, Department of Gastroenterology and Hepatology, Amersfoort, the Netherlands;
, Elisabeth BloemenaDepartment of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands;
, Gijsbert den HartogDepartment of Gastroenterology and Hepatology, Rijnstate Hospital, Arnhem, the Netherlands;
, Dik B. WesterveldIsala Clinics, Department of Gastroenterology and Hepatology, Zwolle, the Netherlands;
, Marco C. BecxDepartment of Gastroenterology and Hepatology, Sint Antonius Hospital, Nieuwegein, the Netherlands;
, Maurice G. RusselDepartment of Gastroenterology and Hepatology, Medisch Spectrum Twente, Enschede, the Netherlands;
, Birgit I. Lissenberg-WitteDepartment of Epidemiology and Biostatistics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands;
http://orcid.org/0000-0001-9448-1826
Carin M. van NieuwkerkDepartment of Gastroenterology and Hepatology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands;
, Chris J. J. MulderDepartment of Gastroenterology and Hepatology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands;
, Joanne VerheijDepartment of Pathology, Amsterdam UMC, Academical Medical Center, Amsterdam, the Netherlands;
& Adriaan A. van BodegravenDepartment of Gastroenterology and Hepatology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; ;Zuyderland Medical Centre, Department of Gastroenterology, Geriatrics, Internal and Intensive Care Medicine (Co-MIK), Sittard-Geleen-Heerlen, the Netherlands
show all
Pages 753-760
|
Received 12 Mar 2019, Accepted 27 May 2019, Published online: 16 Jun 2019
Related Research Data
Thiopurine therapy in inflammatory bowel disease patients: Analyses of two 8-year intercept cohorts
Source:
Oxford University Press (OUP)
Histopathology of liver biopsies from a thiopurine-naïve inflammatory bowel disease cohort: Prevalence of nodular regenerative hyperplasia
Source:
Informa UK Limited
Azathioprine induced nodular regenerative hyperplasia in IBD patients
Source:
Elsevier BV
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
Source:
Massachusetts Medical Society
6-Thioguanine Treatment in Inflammatory Bowel Disease: A Critical Appraisal by a European 6-TG Working Party
Source:
S. Karger AG
Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions
Source:
Ovid Technologies (Wolters Kluwer Health)
Clinical Course of Nodular Regenerative Hyperplasia in Thiopurine Treated Inflammatory Bowel Disease Patients
Source:
Elsevier BV
The Prevalence of Nodular Regenerative Hyperplasia in Inflammatory Bowel Disease Patients Treated with Thioguanine Is Not Associated with Clinically Significant Liver Disease
Source:
Oxford University Press (OUP)
Limited relevance and progression of histological alterations in the liver during thioguanine therapy in inflammatory bowel disease patients
Source:
Informa UK Limited
Nodular regenerative hyperplasia: evolving concepts on underdiagnosed cause of portal hypertension.
Source:
Baishideng Publishing Group Inc.
6-thioguanine associated nodular regenerative hyperplasia in patients with inflammatory bowel disease may induce portal hypertension.
Source:
Ovid Technologies (Wolters Kluwer Health)
Limited relevance and progression of histological alterations in the liver during thioguanine therapy in inflammatory bowel disease patients
Source:
Informa UK Limited
6-thioguanine can cause serious liver injury in inflammatory bowel disease patients
Source:
Elsevier BV
Perspectives on NASH Histology: Cellular Ballooning
Source:
Elsevier BV
Limited relevance and progression of histological alterations in the liver during thioguanine therapy in inflammatory bowel disease patients
Source:
Informa UK Limited
Perspectives on NASH Histology: Cellular Ballooning
Source:
Elsevier BV
Limited relevance and progression of histological alterations in the liver during thioguanine therapy in inflammatory bowel disease patients
Source:
Informa UK Limited
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.